| Year |
Citation |
Score |
| 2018 |
Grimm FA, Blanchette A, House JS, Ferguson K, Hsieh NH, Dalaijamts C, Wright AA, Anson B, Wright FA, Chiu WA, Rusyn I. A human population-based organotypic in vitro model for cardiotoxicity screening. Altex. PMID 29999168 DOI: 10.14573/Altex.1805301 |
0.334 |
|
| 2018 |
Millard D, Dang Q, Shi H, Zhang X, Strock C, Kraushaar U, Zeng H, Levesque P, Lu HR, Guillon JM, Wu JC, Li Y, Luerman G, Anson B, Guo L, et al. Cross-Site Reliability of Human Induced Pluripotent Stem-Cell Derived Cardiomyocyte Based Safety Assays using Microelectrode Arrays: Results from a Blinded CiPA Pilot Study. Toxicological Sciences : An Official Journal of the Society of Toxicology. PMID 29718449 DOI: 10.1093/Toxsci/Kfy110 |
0.391 |
|
| 2017 |
Sirenko O, Grimm FA, Ryan KR, Iwata Y, Chiu WA, Parham F, Wignall JA, Anson B, Cromwell EF, Behl M, Rusyn I, Tice RR. In vitro cardiotoxicity assessment of environmental chemicals using an organotypic human induced pluripotent stem cell-derived model. Toxicology and Applied Pharmacology. PMID 28259702 DOI: 10.1016/J.Taap.2017.02.020 |
0.338 |
|
| 2017 |
Zamora V, Hortigon-Vinagre MP, Burton F, Taylor A, Anson B, Craig MA, Smith G. Medium Through-put Electrophysiological and Inotropic Studies on iCell 2 hiPSC-Derived Cardiomyocytes Using the CellOPTIQ® Platform Journal of Pharmacological and Toxicological Methods. 88: 243. DOI: 10.1016/J.Vascn.2017.09.245 |
0.331 |
|
| 2017 |
Carlson C, Hancock M, Thomson A, Anson B, Mann D. Detection of Xenobiotic-Induced Hepatotoxicity in Human iPSC-Derived iCell Hepatocytes 2.0 Journal of Pharmacological and Toxicological Methods. 88: 236. DOI: 10.1016/j.vascn.2017.09.223 |
0.326 |
|
| 2017 |
Anson B, Feaster T, Jarecki B, Thompson A. Advances in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Maintaining Validated Responses While Accelerating Workflows Journal of Pharmacological and Toxicological Methods. 88: 235. DOI: 10.1016/j.vascn.2017.09.220 |
0.367 |
|
| 2015 |
Drowley L, Koonce C, Peel S, Jonebring A, Plowright AT, Kattman SJ, Andersson H, Anson B, Swanson BJ, Wang QD, Brolen G. Human iPSC-Derived Cardiac Progenitor Cells in Phenotypic Screening: A Transforming Growth Factor-β Type 1 Receptor Kinase Inhibitor Induces Efficient Cardiac Differentiation. Stem Cells Translational Medicine. PMID 26683871 DOI: 10.5966/Sctm.2015-0114 |
0.394 |
|
| 2015 |
Jones D, Liu F, Anson B, Fiene S, Trudeau M, Robertson G. Loss of hERG 1b is arrhythmogenic in human cardiomyocytes Journal of Pharmacological and Toxicological Methods. 75: 166-167. DOI: 10.1016/J.Vascn.2015.08.031 |
0.487 |
|
| 2015 |
Jones E, Carlson CB, Koonce C, Aoyama N, Wang J, Meline B, Kattman SJ, Anson B. Human iPS Cell-Derived Cardiomyocytes Carrying MHC-R403Q Exhibit Aspects of Hypertrophic Cardiomyopathy in vitro Biophysical Journal. 108: 598a. DOI: 10.1016/J.Bpj.2014.11.3253 |
0.354 |
|
| 2014 |
Smith G, Cooper J, Hortigon-Vinagre M, Ghouri I, Craig M, Anson B, Wallis R. Discrimination power of optically recorded action potentials in cardiomyocytes derived from human induced pluripotent stem cells Journal of Pharmacological and Toxicological Methods. 70: 353. DOI: 10.1016/J.Vascn.2014.03.149 |
0.34 |
|
| 2013 |
Carlson C, Koonce C, Aoyama N, Einhorn S, Fiene S, Thompson A, Swanson B, Anson B, Kattman S. Phenotypic screening with human iPS cell-derived cardiomyocytes: HTS-compatible assays for interrogating cardiac hypertrophy. Journal of Biomolecular Screening. 18: 1203-11. PMID 24071917 DOI: 10.1177/1087057113500812 |
0.39 |
|
| 2013 |
Puppala D, Collis LP, Sun SZ, Bonato V, Chen X, Anson B, Pletcher M, Fermini B, Engle SJ. Comparative gene expression profiling in human-induced pluripotent stem cell--derived cardiocytes and human and cynomolgus heart tissue. Toxicological Sciences : An Official Journal of the Society of Toxicology. 131: 292-301. PMID 22982684 DOI: 10.1093/Toxsci/Kfs282 |
0.332 |
|
| 2013 |
Sirenko O, Crittenden C, Callamaras N, Hesley J, Chen YW, Funes C, Rusyn I, Anson B, Cromwell EF. Multiparameter in vitro assessment of compound effects on cardiomyocyte physiology using iPSC cells. Journal of Biomolecular Screening. 18: 39-53. PMID 22972846 DOI: 10.1177/1087057112457590 |
0.41 |
|
| 2012 |
Schrøder RL, Christensen M, Anson B, Sunesen M. Exploring Stem Cell-Derived Cardiomyocytes with Automated Patch Clamp Techniques Biophysical Journal. 102: 544a. DOI: 10.1016/J.BPJ.2011.11.2968 |
0.374 |
|
| 2011 |
Ma J, Guo L, Fiene SJ, Anson BD, Thomson JA, Kamp TJ, Kolaja KL, Swanson BJ, January CT. High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents. American Journal of Physiology. Heart and Circulatory Physiology. 301: H2006-17. PMID 21890694 DOI: 10.1152/Ajpheart.00694.2011 |
0.342 |
|
| 2011 |
Guo L, Abrams R, Anson B, Kolaja K. Defining pharmacological and toxicological actions of cardiac glycosides by MEA in human iPS-derived cardiomyocytes Journal of Pharmacological and Toxicological Methods. 64: e14-e15. DOI: 10.1016/J.VASCN.2011.03.054 |
0.36 |
|
| 2009 |
Bryant S, Wyllie C, Palmer R, Heal R, Demmon J, Nicol S, Anson B, Rudy-Reil D, Ma J. Effects of isoprenaline on human stem cell derived cardiomyocytes Journal of Pharmacological and Toxicological Methods. 60: 219-220. DOI: 10.1016/J.VASCN.2009.04.054 |
0.373 |
|
| 2006 |
Rajamani S, Anderson CL, Valdivia CR, Eckhardt LL, Foell JD, Robertson GA, Kamp TJ, Makielski JC, Anson BD, January CT. Specific serine proteases selectively damage KCNH2 (hERG1) potassium channels and I(Kr). American Journal of Physiology. Heart and Circulatory Physiology. 290: H1278-88. PMID 16227340 DOI: 10.1152/Ajpheart.00777.2005 |
0.477 |
|
| 2003 |
Keyser MR, Anson BD, Titus SA, Ganetzky B, Witten JL. Molecular characterization, functional expression, and developmental profile of an ether à -go-go K+ channel in the tobacco hornworm Manduca sexta. Journal of Neurobiology. 55: 73-85. PMID 12605460 DOI: 10.1002/Neu.10188 |
0.479 |
|
| Show low-probability matches. |